Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription 26.02.2024 1 Am J Obstet Gynecol 1 Ann Intern Med 3 Antiviral Res 4 BMJ 9 Clin Infect Dis 1 Graefes Arch Clin Exp Ophthalmol 2 Infect Control Hosp Epidemiol 3 Int J Infect Dis 1 Intensive Care Med 3 J Infect 4 J Med Virol 1 J Travel Med 2 J Virol 1 JAMA 1 Lancet 3 Lancet Infect Dis 3 MMWR Morb Mortal Wkly Rep 4 N Engl J Med 3 Nature 1 Pol J Radiol 1 Radiology 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. BARROS FC, Gunier RB, Rego A, Sentilhes L, et al
   Maternal Vaccination Against COVID-19 and Neonatal Outcomes During Omicron: INTERCOVID-2022 Study.
   Am J Obstet Gynecol. 2024 Feb 15:S0002-9378(24)00078.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. 
   Correction: SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy.
   Ann Intern Med. 2024 Feb 20. doi: 10.7326/L24-0045.
   PubMed        
   
   

   
   Antiviral Res

3. TAM EH, Peng Y, Yan Cheah MX, Yan C, et al
   Neutralizing antibodies to block viral entry and for identification of entry inhibitors.
   Antiviral Res. 2024 Feb 16:105834. doi: 10.1016/j.antiviral.2024.105834.
   PubMed         Abstract available
   
   
4. SANTOS-FERREIRA N, Van Dycke J, Chiu W, Neyts J, et al
   Molnupiravir inhibits human norovirus and rotavirus replication in 3D human intestinal enteroids.
   Antiviral Res. 2024;223:105839.
   PubMed         Abstract available
   
   
5. BIGOTTI MG, Klein K, Gan ES, Anastasina M, et al
   The alpha-dystroglycan N-terminus is a broad-spectrum antiviral agent against SARS-CoV-2 and enveloped viruses.
   Antiviral Res. 2024 Feb 20:105837. doi: 10.1016/j.antiviral.2024.105837.
   PubMed         Abstract available
   
   

   
   BMJ

6. 
   Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study.
   BMJ. 2024;384:q434.
   PubMed        
   
   
7. 
   US workers during the covid-19 pandemic: uneven risks, inadequate protections, and predictable consequences.
   BMJ. 2024;384:q432.
   PubMed        
   
   
8. WISE J
   GMC admits error in decision over whether to investigate doctor's claims over covid vaccine.
   BMJ. 2024;384:q433.
   PubMed        
   
   
9. LEMASTERS K, Brinkley-Rubinstein L
   Covid-19 in US jails and prisons: implications for the next public health crisis.
   BMJ. 2024;384:e076975.
   PubMed        
   
   

   
   Clin Infect Dis

10. TOWNLEY B, Akin D, Dimaguila GL, Sawires R, et al
    Exploring the infectious contribution to intussusception causality using the effects of COVID-19 lockdowns in Australia: An ecological study.
    Clin Infect Dis. 2024 Feb 20:ciae084. doi: 10.1093.
    PubMed         Abstract available
    
    
11. AGGARWAL NR, Nordwall J, Braun DL, Chung L, et al
    Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
    Clin Infect Dis. 2024 Feb 20:ciad780. doi: 10.1093.
    PubMed         Abstract available
    
    
12. TROSEID M
    Viral, Host Factors or Both as Coronavirus Disease 2019 (COVID-19) Biomarkers.
    Clin Infect Dis. 2024 Feb 20:ciad779. doi: 10.1093.
    PubMed        
    
    
13. FOLLMANN D, Mateja A, Fay MP, Magaret CA, et al
    Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
    Clin Infect Dis. 2024 Feb 19:ciae081. doi: 10.1093.
    PubMed         Abstract available
    
    
14. MONTEJANO R, Arribas JR
    COVID-19 Clinical Trials: Are Adaptive Methodologies the Solution?
    Clin Infect Dis. 2024 Feb 17:ciae079. doi: 10.1093.
    PubMed        
    
    
15. GIACOMELLI A, Antinori S, Gori A, Cozzi-Lepri A, et al
    COVID-19: find the right questions to be answered.
    Clin Infect Dis. 2024 Feb 17:ciae078. doi: 10.1093.
    PubMed        
    
    
16. TOEPFER AP, Amarin JZ, Spieker AJ, Stewart LS, et al
    Seasonality, clinical characteristics, and outcomes of respiratory syncytial virus disease by subtype among children less than five years old, New Vaccine Surveillance Network, United States, 2016-2020.
    Clin Infect Dis. 2024 Feb 15:ciae085. doi: 10.1093.
    PubMed         Abstract available
    
    
17. KOMOROWSKI AS, Lo CKL, Kapoor AK, Smieja M, et al
    More Than a Decade Since the Latest CONSORT Non-inferiority Trials Extension: Do Infectious Diseases Trials Do Enough?
    Clin Infect Dis. 2024;78:324-329.
    PubMed         Abstract available
    
    
18. KARMARKAR EN, Fitzpatrick T, Himmelfarb ST, Chow EJ, et al
    Cluster of non-toxigenic Corynebacterium diphtheriae infective endocarditis and rising background C. diphtheriae cases-Seattle, Washington 2020-2023.
    Clin Infect Dis. 2024 Feb 21:ciae094. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Graefes Arch Clin Exp Ophthalmol

19. CAI J, Li X, Li Q, Cai Y, et al
    Clinical characteristics of acute acquired concomitant esotropia before and after the COVID-19 pandemic: a retrospective analysis.
    Graefes Arch Clin Exp Ophthalmol. 2024 Feb 22. doi: 10.1007/s00417-024-06416.
    PubMed         Abstract available
    
    

    
    Infect Control Hosp Epidemiol

20. WHITING KA, Guest R, Seshan VE, Kamboj M, et al
    Susceptibility of healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) hybrid immunity to XBB lineage reinfection.
    Infect Control Hosp Epidemiol. 2024 Feb 20:1-4. doi: 10.1017/ice.2023.
    PubMed         Abstract available
    
    
21. BOUGES S, Jouzeau A, Lieutier-Colas F, Pefau M, et al
    Antibiotic consumption in French nursing homes between 2018 and 2022: A multicenter survey.
    Infect Control Hosp Epidemiol. 2024 Feb 19:1-6. doi: 10.1017/ice.2024.
    PubMed         Abstract available
    
    

    
    Int J Infect Dis

22. IKEBE T, Okuno R, Uchitani Y, Yamaguchi T, et al
    Epidemiological shifts in and impact of COVID-19 on streptococcal toxic shock syndrome in Japan: A genotypic analysis of Group A Streptococcus isolates.
    Int J Infect Dis. 2024 Feb 19:S1201-9712(24)00022.
    PubMed         Abstract available
    
    
23. BERENTSCHOT JC, Martine Bek L, Heijenbrok-Kal MH, van den Berg-Emons RJG, et al
    Acute COVID-19 treatment is not associated with health problems 2 years after hospitalization.
    Int J Infect Dis. 2024 Feb 15:S1201-9712(24)00036.
    PubMed         Abstract available
    
    
24. BIANCHI FP, Rizzi D, Daleno A, Stefanizzi P, et al
    Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study.
    Int J Infect Dis. 2024 Feb 14:S1201-9712(24)00028.
    PubMed         Abstract available
    
    

    
    Intensive Care Med

25. FERNANDO SM, Brodie D, Barbaro RP, Agerstrand C, et al
    Age and associated outcomes among patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory failure: analysis of the Extracorporeal Life Support Organization registry.
    Intensive Care Med. 2024 Feb 20. doi: 10.1007/s00134-024-07343.
    PubMed         Abstract available
    
    

    
    J Infect

26. ZHOU J, Lan L, Ai S, Lin J, et al
    People Living with HIV who have poor immune status are a key population for SARS-CoV-2 prevention.
    J Infect. 2024 Feb 15:106122. doi: 10.1016/j.jinf.2024.106122.
    PubMed        
    
    
27. YAO Z, Zhang L, Duan Y, Tang X, et al
    Molecular Insights into the Adaptive Evolution of SARS-CoV-2 Spike Protein.
    J Infect. 2024 Feb 15:106121. doi: 10.1016/j.jinf.2024.106121.
    PubMed         Abstract available
    
    
28. HITES M, Massonnaud CR, Jamard S, Goehringer F, et al
    Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): a phase 3, randomized, double-blind, placebo-controlled trial.
    J Infect. 2024 Feb 15:106120. doi: 10.1016/j.jinf.2024.106120.
    PubMed        
    
    

    
    J Med Virol

29. GAN J, Zhang H, Wu J, Liu Y, et al
    Effect of inactivated vaccine boosters against severe and critical COVID-19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China.
    J Med Virol. 2024;96:e29402.
    PubMed         Abstract available
    
    
30. CHIRUMBOLO S, Tirelli U
    On coming back, the scaring COVID-19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS-CoV2 spreading.
    J Med Virol. 2024;96:e29490.
    PubMed        
    
    
31. OMBELET S, Castanares-Zapatero D, Desimpel F, Hulstaert F, et al
    Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron: An updated meta-analysis.
    J Med Virol. 2024;96:e29434.
    PubMed         Abstract available
    
    
32. YANG D, Chan JF, Yoon C, Luk TY, et al
    Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.
    J Med Virol. 2024;96:e29472.
    PubMed         Abstract available
    
    

    
    J Travel Med

33. MARTINEZ-LACALZADA M, Cruz A, Subira C, Vera I, et al
    Lack of a non-specific protective effect of prior yellow fever vaccination against COVID-19.
    J Travel Med. 2024 Feb 15:taae027. doi: 10.1093.
    PubMed        
    
    

    
    J Virol

34. HUANG H, Lei X, Zhao C, Qin Y, et al
    Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving IFIT3.
    J Virol. 2024;98:e0168223.
    PubMed         Abstract available
    
    
35. STOLL GA, Nikolopoulos N, Zhai H, Zhang L, et al
    Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
    J Virol. 2024;98:e0177723.
    PubMed         Abstract available
    
    

    
    JAMA

36. HARRIS E
    New Antiviral on the Horizon for Mild to Moderate COVID-19.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729.
    PubMed        
    
    

    
    Lancet

37. VORA NM, Hassan L, Plowright RK, Horton R, et al
    The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
    Lancet. 2024;403:597-599.
    PubMed        
    
    

    
    Lancet Infect Dis

38. LI Y
    Evolution of respiratory syncytial virus burden in young children following the COVID-19 pandemic: influence of concomitant changes in testing practices - Author's reply.
    Lancet Infect Dis. 2024 Feb 15:S1473-3099(24)00082.
    PubMed        
    
    
39. FAFI I, Assad Z, Lenglart L, Valtuille Z, et al
    Evolution of respiratory syncytial virus burden in young children following the COVID-19 pandemic: influence of concomitant changes in testing practices.
    Lancet Infect Dis. 2024 Feb 15:S1473-3099(24)00081.
    PubMed        
    
    
40. PLEY C, Kampmann B
    Access to respiratory syncytial virus preventive tools for neonates and infants in Europe.
    Lancet Infect Dis. 2024 Feb 19:S1473-3099(24)00084.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

41. EDENS C, Clopper BR, DeVies J, Benitez A, et al
    Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:149-151.
    PubMed        
    
    
42. MUSA N, Ghoniem A, Hsu CH, Mubarak S, et al
    Progress Toward Measles Elimination - World Health Organization Eastern Mediterranean Region, 2019-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:139-144.
    PubMed         Abstract available
    
    
43. FORD ND, Agedew A, Dalton AF, Singleton J, et al
    Notes from the Field: Long COVID Prevalence Among Adults - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:135-136.
    PubMed        
    
    

    
    N Engl J Med

44. 
    Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2024;390:772.
    PubMed        
    
    
45. BENEZECH S, Khoryati L, Belot A
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C. Reply.
    N Engl J Med. 2024;390:771-772.
    PubMed        
    
    
46. FRANCO A, Tremoulet A, Burns JC
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
    N Engl J Med. 2024;390:771.
    PubMed        
    
    
47. HERBERT C, McManus DD, Soni A
    Persistent False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:764-765.
    PubMed        
    
    

    
    Nature

48. GHAFARI M, Hall M, Golubchik T, Ayoubkhani D, et al
    Prevalence of persistent SARS-CoV-2 in a large community surveillance study.
    Nature. 2024 Feb 21. doi: 10.1038/s41586-024-07029.
    PubMed         Abstract available
    
    
49. COLLINS PY, Sinha M, Concepcion T, Patton G, et al
    Making cities mental health friendly for adolescents and young adults.
    Nature. 2024 Feb 21. doi: 10.1038/s41586-023-07005.
    PubMed         Abstract available
    
    
50. WONG C
    Largest post-pandemic survey finds trust in scientists is high.
    Nature. 2024;626:704.
    PubMed        
    
    

    
    Pol J Radiol

51. LESZCZYNSKI W, Kazimierczak W, Lemanowicz A, Serafin Z, et al
    Texture analysis of chest X-ray images for the diagnosis of COVID-19 pneumonia.
    Pol J Radiol. 2024;89:e49-e53.
    PubMed         Abstract available
    
    

    
    Radiology

52. NECKER F, Petkov K, Engel K, Scholz M, et al
    Evolution of an Acute COVID-19 Pulmonary Infection.
    Radiology. 2024;310:e232644.
    PubMed        
    
    

    
    Science

53. JAYCOX JR, Dai Y, Ring AM
    Decoding the autoantibody reactome.
    Science. 2024;383:705-707.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.